Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics

In recent studies, the reported prevalence of heterozygous familial hypercholesterolemia (FH) has been higher than in previous reports. Although cascade genetic screening is a good option for efficient identification of affected patients, diagnosis using only clinical criteria is more common in real...

Descripción completa

Detalles Bibliográficos
Autor principal: Lee, Sang-Hak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368119/
https://www.ncbi.nlm.nih.gov/pubmed/28116871
http://dx.doi.org/10.3803/EnM.2017.32.1.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368119/
https://www.ncbi.nlm.nih.gov/pubmed/28116871
http://dx.doi.org/10.3803/EnM.2017.32.1.36

Ejemplares similares